Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
25 09 2019
Historique:
received: 05 01 2018
revised: 27 12 2018
accepted: 11 05 2019
entrez: 27 9 2019
pubmed: 27 9 2019
medline: 21 8 2020
Statut: ppublish

Résumé

Variants in the leucine-rich repeat kinase-2 (

Identifiants

pubmed: 31554740
pii: 11/511/eaas9292
doi: 10.1126/scitranslmed.aas9292
pii:
doi:

Substances chimiques

Reactive Oxygen Species 0
alpha-Synuclein 0
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Bojan Shutinoski (B)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.

Mansoureh Hakimi (M)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.

Irene E Harmsen (IE)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Michaela Lunn (M)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Department of Neuroscience, Carleton University, Ottawa, ON, Canada.

Juliana Rocha (J)

Department of Immunology, University of Toronto, Toronto, ON, Canada.

Nathalie Lengacher (N)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Yi Yuan Zhou (YY)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Jasmine Khan (J)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Angela Nguyen (A)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Quinton Hake-Volling (Q)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Daniel El-Kodsi (D)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Juan Li (J)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Azadeh Alikashani (A)

Research Centre, Montreal Heart Institute, Montréal, QC, Canada.
Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.

Claudine Beauchamp (C)

Research Centre, Montreal Heart Institute, Montréal, QC, Canada.
Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.

Jay Majithia (J)

Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.

Kevin Coombs (K)

Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada.

Derya Shimshek (D)

Novartis Institutes of BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland.

Paul C Marcogliese (PC)

Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
University of Ottawa Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada.

David S Park (DS)

Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
University of Ottawa Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada.

John D Rioux (JD)

Research Centre, Montreal Heart Institute, Montréal, QC, Canada.
Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.

Dana J Philpott (DJ)

Department of Immunology, University of Toronto, Toronto, ON, Canada.

John M Woulfe (JM)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada.

Shawn Hayley (S)

Department of Neuroscience, Carleton University, Ottawa, ON, Canada.

Subash Sad (S)

Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.

Julianna J Tomlinson (JJ)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
University of Ottawa Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada.

Earl G Brown (EG)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.

Michael G Schlossmacher (MG)

Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada. mschlossmacher@ohri.ca.
Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
University of Ottawa Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada.
Division of Neurology, Department of Medicine, Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH